Related Experiment Video
Updated: Jan 22, 2026

Separation of Plasmodium falciparum Late Stage-infected Erythrocytes by Magnetic Means
Published on: March 2, 2013
Metacaspase-3 of Plasmodium falciparum: An atypical trypsin-like serine protease
Bhumika Kumar1, Sonia Verma2, Mohammad Kashif3
1National Institute of Malaria Research, New Delhi, 110077, India; Department of Bioscience, Jamia Millia Islamia, New Delhi 110025, India.
Abstract:
Metacaspases are clan CD cysteine peptidases found in plants, fungi and protozoa that possess a conserved Peptidase_C14 domain, homologous to the human caspases and a catalytic His/Cys dyad. Earlier reports have indicated the role of metacaspases in cell death; however, metacaspases of human malaria parasite remains poorly understood. In this study, we aimed to functionally characterize a novel malarial protease, P. falciparum metacaspase-3 (PfMCA3). Unlike other clan CD peptidases, PfMCA3 has an atypical active site serine (Ser1865) residue in place of canonical cysteine and it phylogenetically forms a distinct branch across the species. To investigate whether this domain retains catalytic activity, we expressed, purified and refolded the Peptidase_C14 domain of PfMCA3 which was found to express in all asexual stages. PfMCA3 exhibited trypsin-like serine protease activity with ser1865 acting as catalytic residue to cleave trypsin oligopeptide substrate. PfMCA3 is inhibited by trypsin-like serine protease inhibitors. Our study found that PfMCA3 enzymatic activity was abrogated when catalytic serine1865 (S1865A) was mutated. Moreover, PfMCA3 was found to be inactive against caspase substrate. Overall, our study characterizes a novel metacaspase of P. falciparum, different from human caspases and not responsible for the caspase-like activity, therefore, could be considered as a potential chemotherapeutic target.
Insights
This study characterizes Plasmodium falciparum metacaspase-3 (PfMCA3), a novel serine protease distinct from human caspases. PfMCA3 exhibits trypsin-like activity and represents a potential therapeutic target for malaria.
Area of Science:
- Biochemistry
- Parasitology
- Molecular Biology
Background:
- Metacaspases are cysteine peptidases involved in cell death, but their role in malaria parasites is unclear.
- Human malaria parasite Plasmodium falciparum metacaspase-3 (PfMCA3) is a novel protease with an atypical active site.
Purpose of the Study:
- To functionally characterize the malarial protease PfMCA3.
- To determine if PfMCA3 possesses catalytic activity and its substrate specificity.
Main Methods:
- Expression, purification, and refolding of the Peptidase_C14 domain of PfMCA3.
- Enzymatic assays using trypsin oligopeptide substrate and caspase substrates.
- Site-directed mutagenesis (S1865A) to investigate catalytic residue function.
- Inhibition assays with serine protease inhibitors.
Main Results:
- PfMCA3 expresses in all asexual stages of P. falciparum.
- PfMCA3 exhibits trypsin-like serine protease activity, with Ser1865 as the catalytic residue.
- PfMCA3 activity is inhibited by serine protease inhibitors and abrogated by S1865A mutation.
- PfMCA3 is inactive against caspase substrates, distinguishing it from human caspases.
Conclusions:
- PfMCA3 is a novel serine protease with unique characteristics, distinct from human caspases.
- PfMCA3's enzymatic activity is dependent on its catalytic serine residue.
- PfMCA3 represents a potential chemotherapeutic target for malaria due to its unique properties.
Related Concept Videos
Antipsychotic Drugs: Typical and Atypical Agents
ortho–para-Directing Activators: –CH3, –OH, –⁠NH2, –OCH3
Piaget's Stage 3 of Cognitive Development
Conservation and Constancy of Quantity
A significant cognitive milestone in the...
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
Conservative Site-specific Recombination and Phase Variation
The recognition sites for Cre recombinase called LoxP...
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....

